Table 1.
Demographic and clinical characteristics of the studied SLE patients and controls.
| Demographic variable | Cases (n=73) (%) | Controls (n=46) (%) |
|---|---|---|
| Female | 66 (90.4) | 31 (67.3) |
| Mean age | 28.4 years | 35.0 years |
| Comorbidity | 22 (30.14) | 0 |
| Low & high disease activity | 25/73, 48/43 | |
| Low dose steroid | 29(39.7) | |
| PGA (VAS <1) | 26 (35.6) | |
| Ever leucopenia | 37 (50.7) | |
| dsDNA ever positive | 48 (65.8) | |
| Complement ever low | 58 (79.5) | |
| Past tuberculosis | 9 (12.3) | |
| BILAG A mucocutaneous | 12 (16.4) | |
| BILAG A neurological | 9 (12.3) | |
| BILAG A musculoskeletal | 3 (4.1) | |
| BILAG A cardiorespiratory | 7 (9.6) | |
| BILAG A gastrointestinal | 3 (4.1) | |
| BILAG A renal | 28 (38.4) | |
| BILAG A haematological | 5 (6.9) | |
| SLE damage - AVN hip | 3 (4.1) | |
| SLE damage – PAH | 4 (5.6) |